Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Yun Li
AddedFeb 16, 2024
UpdatedMay 31, 2026
Yun Li

Yun Li

CEO, VIC Technology Venture Development

CrunchbaseThe Org

Yun Li's Career

VIC Technology Venture Development
VIC Technology Venture Development

Fayetteville, NC, US

CEO· C-Suite · Management
Filtravate
Filtravate

Las Cruces, NM, US

CEO· C-Suite · Management
Nob Hill Therapeutics
Nob Hill Therapeutics

Albuquerque, NM, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Yun Li's Career

VIC Technology Venture Development
VIC Technology Venture Development
Investment FirmInvestment Firm$2.2M412000Fayetteville, NC, US
CEO· C-Suite · Management

Leadership at VIC Technology Venture Development

Bruce YoungBruce YoungCo-Founder
Calvin GoforthCalvin GoforthCo-Founder

Similar to VIC Technology Venture Development

VT Technology VenturesVT Technology VenturesBoston, MA, USest. 2015VT Technology VenturesBoston, MA, US · est. 2015

VT Technology Ventures: Boston-based VC firm specializing in accelerating tech startups' growth.

Investment Firm2
Vibranium Venture CapitalVibranium Venture CapitalMenlo Park, CA, USest. 2021Vibranium Venture CapitalMenlo Park, CA, US · est. 2021

Vibranium.VC: A Silicon Valley-based venture fund investing in seed-stage B2B SaaS startups globally.

Investment Firm8
V1.VCV1.VCSan Francisco, CA, USest. 2015V1.VCSan Francisco, CA, US · est. 2015

v1 vc, LP: A North American venture capital firm investing in early-stage tech and software companies.

Investment Firm4
V CapitalV CapitalChicago, IL, USest. 2015V CapitalChicago, IL, US · est. 2015

VCapital: A full-service venture capital firm, leveraging research and experience to drive investor returns.

Investment Firm14
Filtravate
Filtravate
Seed$250k72020Las Cruces, NM, US
CEO· C-Suite · Management

Leadership at Filtravate

Reza FoudaziReza FoudaziFounder

Similar to Filtravate

Aqua MembranesAqua MembranesAlbuquerque, NM, USRO Membranes, Water Filtrationest. 2011Aqua MembranesAlbuquerque, NM, US · est. 2011

Aqua Membranes: Pioneering RO membrane filtration and chemical preparations since 2011.

Series B · $2.1M7
SmartFlow TechnologiesSmartFlow TechnologiesApex, NC, USFilter Modules, Purification Solutionsest. 1989SmartFlow TechnologiesApex, NC, US · est. 1989

SmartFlow Technologies: Innovating bioprocessing with high-yield, efficient purification and separation solutions.

Seed · $7.7M25
Cloud Water FiltersCloud Water FiltersSan Diego, CA, USWater Filtersest. 2021Cloud Water FiltersSan Diego, CA, US · est. 2021

Cloud: A water brand committed to providing toxin-free, nutrient-rich water through filtration.

Pre-Seed · $2.3M6
Compact Membrane SystemsCompact Membrane SystemsWilmington, DE, USCarbon Capture, Gas Separationest. 1993Compact Membrane SystemsWilmington, DE, US · est. 1993

US-based Compact Membrane Systems, Inc., founded in 1993, specializes in clinical laboratory testing services.

Series A · $16.5M46
Nob Hill Therapeutics
Nob Hill Therapeutics
Angel$167.5k62016Albuquerque, NM, US
CEO· C-Suite · Management

Leadership at Nob Hill Therapeutics

Paul AtkinsPaul AtkinsBoard Member

Similar to Nob Hill Therapeutics

Respira TherapeuticsRespira TherapeuticsAlbuquerque, NM, USDrug Delivery, Inhalationest. 2010Respira TherapeuticsAlbuquerque, NM, US · est. 2010

Respira: A drug delivery tech company specializing in efficient dry powder inhaler technologies.

Series B · $5.1M9
NMB TherapeuticsNMB TherapeuticsHempstead, NY, USDrug Deliveryest. 2018NMB TherapeuticsHempstead, NY, US · est. 2018

NMB Therapeutics: Enhancing drug delivery through nanotechnology for improved patient outcomes. Based in NY, founded 2018.

Seed · $60k6
Nasus MedicalNasus MedicalMesa, AZ, USDrug DeliveryNasus MedicalMesa, AZ, US

Nasus Medical: Non-invasive, affordable sinusitis treatment via a rapid-acting drug delivery platform.

Angel · $256k6
NovaDel PharmaNovaDel PharmaBranchburg, NJ, USPharmaceuticalsest. 1982NovaDel PharmaBranchburg, NJ, US · est. 1982

NovaDel Pharma Inc. develops novel drug delivery systems, enhancing speed, safety, and convenience of medication intake.

Public · $14M4

Yun Li's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakLee Sirg-OoLee Sirg-OoCEO · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialWILL WEI CHENGWILL WEI CHENGCo-Founder & CEO · DiDiHong Eun-taekHong Eun-taekCEO · KakaoAshish DaveAshish DaveCEO · Mirae AssetChoi Soo-yeonChoi Soo-yeonCEO · NaverMickey MikitaniMickey MikitaniCEO · Rakuten

People Similar to Yun Li

Neil InalaNeil InalaCEO · Nobias TherapeuticsJeb KeiperJeb KeiperCEO · Nimbus TherapeuticsNadav Ben-ChanochNadav Ben-ChanochFounder · NobaMac DavidsonMac DavidsonFounder · LinkedInLawrence SamanthaLawrence SamanthaCo-Founder · eEventBlair WalshBlair WalshCEO · Nobi